Member Info for Shukan

We also know that we can expect a tie up with a partner for ongoing research /funding appointment of Dr Shepherd is stage 1 of that process

Yeah load up territory that - Tell me the negatives? Nothing has changed from day one of RTO at 3.5p except we now know that CDX antibodies attack and kill the WORSE kind of blood cancers which is AML, on top of that we now have a new patented (pending) human mouse model , that not only will be used for infusion of CDX but will be a source of income to Hemogenyx from other Biotech’s - and in negotiations.

Your wrong again run a business dealing with the education sector - so Vlad is misleading the market and shareholders - mate what ever your smoking you need to stop

In conjunction with the Acquisition, the Company has raised £2m through the issue of 57,142,857 New Ordinary Shares in a Placing and Subscription at a price of 3.5p per share, plus 1 for 2 warrants to qualifying shareholders over 62,021,429 New Ordinary Shares at 4.0p per share. Optiva Securities Ltd, Shard Capital Partners LLP and Peterhouse Corporate Finance Limited, acted as agents for the Company.

You will find DD hides behind a false identity, because he does not have the “B” to reveal who he really is - any idiot can be a keyboard warrior- we have one here for sure

Tell that to Dr Vladislav- 3.54m into the latest video the researcher ask “how important is this new patent for huminised mice ?” Listen very carefully to Dr Vladislav answer - Domestos Dave no matter how you try to de bunk every announcement the company makes you will find me waiting for you to actually point others here to facts by actual research. https://twitter.com/shukan007/status/971822671733428225?s=21

the new humanised mice (patented) will be the CDX - antibodies testing ground for attacking and killing AML - human blood human AML Cancer cells within the model

Revenues for #HEMO with interested biotech,s looking at the new humanised mice for their respective research programs

Tell me who is making much profit down here - those decent profit takers are long gone at 6-5-4 the trades are small - so what has changed from Vlad,s game changing tweet that their CDX- antibodies attack and kill AML cancer cells - we have bought on board a pioneer in cancer research - NOTHING has changed towards the downside that is why fools sell down here because there is only upside

NO because they have not been issued- next question

Hemogenyx will place on success- they stated this at the presentation evening, they have a loyal following of LTH locked in since RTO, certainly do not want to upset the apple cart no matter what the ill-informed say. THE RTO was at 3.5p with cash in the bank, also the patented mice models will bring additional income , let the fools sell from the impatience to the patience - its a long road

A lot of rubbish been spouted around very comical this board

For now- Hemogenyx placing each piece of the jigsaw on the table with the latest appointment we move on to further developments with the company, patience the only requirement here.

Well the excitement was short lived

FAKE tweet , company confirms it

Close the door behind you- Travia walking out in the manner he did was the red flag, so he knew this was a dead duck. FCA need to get involved.

Show the evidence- you seem very knowledgeable on such matters- waiting

by the way its not years to human trials- I was at the presentation, they have a game plan and all on track, in fact a two way track if you can understand their bio tech , one of the reasons I have hooked up with a humanized mouse researcher, loads of insight into this play

Chris wake up - there will always be sellers, it,s the researched and those that believe in the fundamentals that buy and stick of course its not a quick play - a guy of that calibre that comes on board, well work it out for your self

Mop them up - few more at 4.2p